|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| A61K 31/385 | (2006.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 33/24 | (2019.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Patento numeris | 2947098 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15166232.7 |
| Europos patento paraiškos padavimo data | 2009-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 226910 P | 2009-07-20 | US | |
| 462168 | 2009-07-30 | US | |
| PCT/US2009/0522 | 2009-07-30 | WO |
| (72) |
LEE, Francis, Y., US
JURE-KUNKEL, Maria, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES |
| COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES |